These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2406852)

  • 21. Factors influencing the eradication of Helicobacter pylori with triple therapy.
    Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
    Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo susceptibility of Campylobacter pylori.
    Graham DY; Klein PD; Opekun AR; Smith KE; Polasani RR; Evans DJ; Evans DG; Alpert LC; Michaletz PA; Yoshimura HH
    Am J Gastroenterol; 1989 Mar; 84(3):233-8. PubMed ID: 2919580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children.
    Israel DM; Hassall E
    J Pediatr; 1993 Jul; 123(1):53-8. PubMed ID: 8320625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.
    Hui WM; Lam SK; Ho J; Ng I; Lau WY; Branicki FJ; Lai CL; Lok AS; Ng MM; Fok J
    Am J Med; 1989 Jun; 86(6A):60-5. PubMed ID: 2660558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Campylobacter pylori: its link to gastritis and peptic ulcer disease.
    Marshall BJ
    Rev Infect Dis; 1990; 12 Suppl 1():S87-93. PubMed ID: 2406862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 28. Nodular gastritis and Helicobacter pylori.
    Bujanover Y; Konikoff F; Baratz M
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):41-4. PubMed ID: 2388131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Campylobacter pylori does not alter gastric acid secretion.
    Montbriand JR; Appelman HD; Cotner EK; Nostrant TT; Elta GH
    Am J Gastroenterol; 1989 Dec; 84(12):1513-6. PubMed ID: 2596452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing.
    Kang JY; Piper DW
    Digestion; 1982; 23(2):73-9. PubMed ID: 7047268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
    Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
    J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
    Andreasen JJ; Andersen LP
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):147-9. PubMed ID: 3591312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
    Shreeve DR; Klass HJ; Jones PE
    Digestion; 1983; 28(2):96-101. PubMed ID: 6360774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.
    Vantrappen G; Rutgeerts P; Broeckaert L; Janssens J
    Gut; 1980 Apr; 21(4):329-33. PubMed ID: 7000628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Campylobacter pylori and therapy with bismuth salts].
    Börsch G
    Med Monatsschr Pharm; 1988 Sep; 11(9):301-7. PubMed ID: 3067064
    [No Abstract]   [Full Text] [Related]  

  • 38. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine.
    Pan SA; Liao CH; Lien GS; Chen SH
    Gastroenterology; 1991 Nov; 101(5):1187-91. PubMed ID: 1936788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease.
    Börsch G; Mai U; Müller KM
    Scand J Gastroenterol Suppl; 1988; 142():101-6. PubMed ID: 3166527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.